FIELD: medicine.
SUBSTANCE: following clinical characteristics are determined for the patient: presence or absence of a hereditary predisposition to the development of cardiovascular diseases (x1); percutaneous coronary interventions with statin intake or without it (x2); initial level of postprandial glucose in blood in mmol/l (x3); presence or absence of a high risk of contrast-induced nephropathy development (x4). The probability of risk is calculated by the formula: P = eF/(1+eF). At that, P is the probability of adverse cardiovascular and cerebrovascular events development within 6 years after scheduled percutaneous coronary interventions; e is the base of the natural logarithm (e=2.7183); F is the calculated value of the function, equal to F(x)=b0+b1⋅x1+b2⋅x2+b3⋅x3+b4⋅x4. If P is less than 0.56, a high risk of adverse cardiovascular and cerebrovascular events is predicted within 6 years after scheduled endovascular myocardium revascularization. If P≥0.56, the course of the disease after endovascular intervention on the coronary arteries is favourable.
EFFECT: method allows to predict the onset of adverse cardiovascular and cerebrovascular events within 6 years after scheduled endovascular myocardium revascularization, which ensures timely use of more active follow-up and treatment strategies.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF LATE FATAL CARDIAC AND CEREBROVASCULAR EVENTS AFTER A PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2683691C1 |
METHOD OF PREDICTING THE RISK OF DEVELOPING ADVERSE CARDIOVASCULAR OUTCOMES WITHIN A YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS WITH STENTING IN PATIENTS WITH STABLE CORONARY HEART DISEASE | 2022 |
|
RU2799146C1 |
METHOD OF SELECTION OF HEART REVASCULARIZATION METHOD USING PARAMETERS OF ECHOCARDIOGRAPHY | 2015 |
|
RU2599974C1 |
METHOD OF ASSESSING THE RISK OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH ACUTE MYOCARDICAL INFARCTION WHO UNDERWENT CORONARY ANGIOGRAPHY AND PERCUTANEOUS CORONARY INTERVENTION | 2020 |
|
RU2742162C1 |
METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS WITHIN 12 MONTHS AFTER ELECTIVE ENDOVASCULAR MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2020 |
|
RU2749485C1 |
METHOD OF PREDICTING DEVELOPMENT OF ADVERSE OUTCOMES OF MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION | 2017 |
|
RU2649517C1 |
METHOD FOR REVASCULARISATION OF MULTIPLE CORONARY BED LESION ACCOMPANYING ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2013 |
|
RU2544096C1 |
METHOD FOR PREDICTION OF DEVELOPING POSTINFARCTION ANGINA AND RECURRENT MYOCARDIAL INFARCTION IN MEN YOUNGER THAN 60 YEARS OLD | 2020 |
|
RU2723057C1 |
METHOD OF PREDICTING PROBABILITY OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WHO HAVE UNDERGONE PLANNED CORONARY MYOCARDIAL REVASCULARIZATION | 2023 |
|
RU2814112C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF ACUTE KIDNEY DAMAGE DURING MYOCARDIAL INFARCTION IN MEN UNDER 60 YEARS | 2022 |
|
RU2784943C1 |
Authors
Dates
2018-01-29—Published
2017-04-12—Filed